Experimental combo aims to boost immune attack on head and neck tumors
Disease control
Not yet recruiting
This early-stage study tests a combination of two drugs—decitabine (a chemotherapy that can reactivate genes) and nivolumab (an immunotherapy that helps the immune system fight cancer)—in people with advanced head and neck cancer that has come back or spread. About 15 participant…
Phase: PHASE1 • Sponsor: Kyunghee Burkitt, DO, PhD • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC